Follow
Immunotherapeutics
Immunotherapeutics: the field of research that behaves with treatment of certain diseases involving immune therapy which can also be termed as "Immunotherapeutics".
FEB 23, 2022
6:00 AM PST
C.E. CREDITS
FEB 23, 2022
6:00 AM PST
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...
DEC 08, 2021
8:00 AM PST
C.E. CREDITS
DEC 08, 2021
8:00 AM PST
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
C.E. CREDITS
Despite the promising results with current approved immunotherapies, all patients do not have the same level of response, and recent efforts have focused on understanding and avoiding immuno...
MAY 18, 2021
7:00 AM PDT
MAY 18, 2021
7:00 AM PDT
Date: May 18, 2021 Time: 7:00am PDT, 10:00am EDT Proteins encoded by mutant genes in cancers can be processed and presented on tumor cell surface by human leukocyte antigen (HLA) molecules,...
APR 20, 2021
5:00 PM CEST
APR 20, 2021
5:00 PM CEST
Date: April 20, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers on Oncology - Professor Joan Seoane Prof. Joan Seoane, Group Leader and Director of the Translational Re...
FEB 10, 2021
8:00 AM PST
C.E. CREDITS
FEB 10, 2021
8:00 AM PST
Date: February 10, 2021 Time: 8:00am (PST), 11:00am (EST) Uncovering the interactions between the immune system and cancer cells or pathogens is key for understanding and controlling both ca...
OCT 20, 2020
9:00 AM PDT
OCT 20, 2020
9:00 AM PDT
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
SEP 23, 2020
6:30 AM PDT
SEP 23, 2020
6:30 AM PDT
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
SEP 17, 2020
12:00 PM PDT
SEP 17, 2020
12:00 PM PDT
Therapeutic antibody can provide key protection or lifesaving treatment for those who haven't been or can’t be vaccinated, or when vaccines don’t “take". We galvan...
AUG 26, 2020
8:00 AM PDT
AUG 26, 2020
8:00 AM PDT
DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
JUL 07, 2020
11:00 AM PDT
JUL 07, 2020
11:00 AM PDT
Immune escape mechanisms such as the induction/recruitment of immunosuppressive cells and the increased expression of various immunosuppressive molecules including PD-1/PD-1 ligands are esse...
JUN 18, 2020
9:00 AM PDT
JUN 18, 2020
9:00 AM PDT
DATE: June 18, 2020 TIME: 9:00am PDT, 12:00pm EDT Despite the success of immunotherapy against several malignancies including melanoma and lung adenocarcinoma, glioblastoma remains the excep...
B cells have recently come into vogue as important contributors to the anti-tumor immune response in cancer patients. Specifically, B cells and the immune structures in which they reside (te...
